| 2026-02-26 | +15.1% | earnings | Seeking Alpha | Enovis Corporation Non-GAAP EPS of $0.95 beats by $0.11, revenue of $576M misses by $6.38M |
| 2026-02-26 | +15.1% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2026-02-26 | +15.1% | news | Finviz | Why Enovis (ENOV) Stock Is Trading Up Today - Finviz |
| 2026-02-26 | +15.1% | news | Quiver Quantitative | Enovis Corporation Reports 2025 Financial Results: 7% Sales Growth with Notable Performance in Reconstructive Segment - Quiver Quantitative |
| 2026-02-26 | +15.1% | earnings | Finviz | Enovis (NYSE:ENOV) Misses Q4 CY2025 Sales Expectations - Finviz |
| 2025-07-18 | -14.9% | news | Yahoo Finance | Enovis, CONMED, Astrana Health, Privia Health, and Waters Corporation Stocks Trade Down, What You Need To Know - Yahoo Finance |
| 2026-02-25 | +10.8% | earnings | Seeking Alpha | Enovis Corporation Q4 2025 Earnings Preview |
| 2026-02-25 | +10.8% | earnings | Finviz | Enovis (ENOV) To Report Earnings Tomorrow: Here Is What To Expect - Finviz |
| 2025-11-10 | +10.5% | news | Seeking Alpha | Enovis Corporation (ENOV) Presents at UBS Global Healthcare Conference 2025 Transcript |
| 2025-11-06 | -9.9% | earnings | Seeking Alpha | Enovis Corporation beats top-line and bottom-line estimates; updates FY25 outlook |
| 2025-11-06 | -9.9% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2026-04-21 | -9.9% | earnings | MarketBeat | Enovis (NYSE:ENOV) Trading Down 7.7% - Here's Why - MarketBeat |
| 2025-08-07 | +9.7% | earnings | Seeking Alpha | Enovis Corporation Non-GAAP EPS of $0.79 beats by $0.07, revenue of $564.55M beats by $9.93M |
| 2025-08-07 | +9.7% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2024-05-02 | -9.6% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2026-01-13 | -9.3% | news | Seeking Alpha | Enovis Corporation (ENOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2026-01-13 | -9.3% | news | Seeking Alpha | Enovis Corporation (ENOV) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow |
| 2026-04-20 | -9.0% | news | Cổng thông tin điện tử Tỉnh Sơn La | What could move Enovis Corporation (ENOV) stock later today (+0.27%) 2026-04-20 - Trending Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2025-11-05 | -8.9% | earnings | Seeking Alpha | Enovis Corporation Q3 2025 Earnings Preview |
| 2023-02-23 | -8.8% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2025-02-26 | -7.9% | earnings | Seeking Alpha | Enovis Corporation (ENOV) Q4 2024 Earnings Call Transcript |
| 2025-02-26 | -7.9% | executive | Seeking Alpha | Enovis says CEO Matt Trerotola to retire |
| 2025-02-26 | -7.9% | earnings | Seeking Alpha | Enovis Corporation beats top-line and bottom-line estimates; initiates FY25 outlook |
| 2025-02-26 | -7.9% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2025-02-26 | -7.9% | legal | SEC EDGAR | ENOV 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-02-25 | -7.7% | earnings | Seeking Alpha | Enovis Corporation Q4 2024 Earnings Preview |
| 2025-11-14 | -7.4% | legal | SEC EDGAR | ENOV 8-K: 5.02 (SEC Filing) |
| 2025-05-11 | +7.3% | earnings | Seeking Alpha | Enovis Corporation (ENOV) Q1 2025 Earnings Call Transcript |
| 2025-05-11 | +7.3% | earnings | Seeking Alpha | Enovis Corporation 2025 Q1 - Results - Earnings Call Presentation |
| 2024-11-06 | +7.2% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2025-08-06 | +7.1% | earnings | Seeking Alpha | Enovis Corporation Q2 2025 Earnings Preview |
| 2022-11-02 | +6.6% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2025-03-14 | +6.6% | legal | SEC EDGAR | ENOV 8-K: 5.02 and (SEC Filing) |
| 2022-02-25 | -6.5% | legal | SEC EDGAR | ENOV 8-K: 5.02 and (SEC Filing) |
| 2025-11-09 | +6.3% | analyst | simplywall.st | Enovis Corporation (NYSE:ENOV) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - simplywall.st |
| 2023-10-19 | -6.2% | legal | SEC EDGAR | ENOV 8-K: 2.02, 7.01, 8.01 (SEC Filing) |
| 2026-03-27 | -5.2% | news | StockStory | Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know |
| 2026-03-27 | -5.2% | news | Simply Wall St. | Undervalued Small Caps With Insider Action Across Regions |
| 2026-03-27 | -5.2% | news | The Globe and Mail | Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know - The Globe and Mail |
| 2023-01-03 | +5.1% | legal | SEC EDGAR | ENOV 8-K: 5.02 (SEC Filing) |
| 2023-08-03 | -5.0% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2024-02-21 | +4.9% | legal | SEC EDGAR | ENOV 8-K: 2.01 and (SEC Filing) |
| 2025-11-07 | +4.8% | earnings | Seeking Alpha | Enovis raises 2025 adjusted EPS guidance to $3.10–$3.25 while sharpening portfolio focus |
| 2025-11-07 | +4.8% | earnings | Seeking Alpha | Enovis Corporation (ENOV) Q3 2025 Earnings Call Transcript |
| 2025-04-02 | -4.8% | executive | Seeking Alpha | Enovis names McDonald as CEO |
| 2025-04-02 | -4.8% | legal | SEC EDGAR | ENOV 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-10-14 | +4.6% | news | StockStory | Why Enovis (ENOV) Stock Is Trading Up Today - StockStory |
| 2026-04-22 | -4.5% | news | Zacks | Despite Fast-paced Momentum, Enovis (ENOV) Is Still a Bargain Stock |
| 2026-04-22 | -4.5% | news | Yahoo Finance | Despite Fast-paced Momentum, Enovis (ENOV) Is Still a Bargain Stock - Yahoo Finance |
| 2026-04-22 | -4.5% | earnings | Xã Thanh Hà | ENOV (Enovis Corporation) shares rise 4.4 percent after 2025 fourth quarter EPS tops analyst estimates by 13 percent. - Growth Acceleration - Xã Thanh Hà |
| 2025-05-07 | -4.1% | earnings | Seeking Alpha | Enovis Corporation Q1 2025 Earnings Preview |
| 2025-05-08 | -4.0% | earnings | Seeking Alpha | Enovis Corporation Non-GAAP EPS of $0.81 beats by $0.07, revenue of $558.8M in-line |
| 2025-05-08 | -4.0% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2025-05-08 | -4.0% | news | Stock Titan | Enovis Announces First Quarter 2025 Results - Stock Titan |
| 2025-01-06 | +4.0% | news | Quiver Quantitative | Enovis Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Quiver Quantitative |
| 2022-04-06 | -3.9% | news | GuruFocus | Enovis Corp (ENOV) Stock Price, Trades & News - GuruFocus |
| 2024-11-22 | +3.9% | news | Seeking Alpha | Enovis Corporation: Reasonably Valued With Caveats |
| 2024-11-22 | +3.9% | news | Seeking Alpha | Enovis Corporation: Reasonably Valued With Caveats (NYSE:ENOV) - Seeking Alpha |
| 2022-02-22 | +3.7% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2023-11-07 | +3.7% | legal | SEC EDGAR | ENOV 8-K: 2.02 (SEC Filing) |
| 2022-03-11 | -3.5% | legal | SEC EDGAR | ENOV 8-K: 5.02, 5.04 (SEC Filing) |
| 2022-04-08 | +3.5% | legal | SEC EDGAR | ENOV 8-K: 1.01, 2.01, 2.03, 3.03, 5.02, 5.03, 8.01 (SEC Filing) |
| 2022-04-08 | +3.5% | earnings | MarketBeat | Enovis (ENOV) Stock Price, News & Analysis - MarketBeat |
| 2022-04-08 | +3.5% | news | marketscreener.com | Colfax Corporation has Changed its Name to Enovis Corporation - marketscreener.com |
| 2025-07-21 | +3.4% | news | simplywall.st | Enovis Corporation's (NYSE:ENOV) Shares Lagging The Industry But So Is The Business - simplywall.st |
| 2026-01-22 | -3.4% | analyst | Insider Monkey | Enovis Corporation (ENOV): Orthopedic Innovation and Growth Potential Drive Analyst Confidence - Insider Monkey |
| 2023-03-15 | -3.3% | legal | SEC EDGAR | ENOV 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-17 | +3.2% | analyst | Benzinga | Analyst Backs Enovis On Cash Flow Turnaround - Benzinga |
| 2025-11-28 | -3.2% | news | Seeking Alpha | Enovis: MedTech Play Is Far From Healthy |
| 2025-11-28 | -3.2% | news | Seeking Alpha | Enovis: MedTech Play Is Far From Healthy (NYSE:ENOV) - Seeking Alpha |
| 2021-07-28 | +3.2% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2026-04-02 | -3.2% | M&A | Zacks | CYH Sustains Its Divestiture Spree Through Alabama Facility Sale |
| 2026-04-02 | -3.2% | news | StockStory | 3 Healthcare Stocks with Open Questions |
| 2026-04-02 | -3.2% | news | Stock Titan | Director at Enovis (NYSE: ENOV) receives 770-share stock grant - Stock Titan |
| 2025-10-08 | +3.1% | news | StockStory | Enovis (ENOV) Stock Trades Up, Here Is Why - StockStory |
| 2025-10-08 | +3.1% | news | Quiver Quantitative | Enovis Corporation Sells Dr. Comfort Diabetic Shoe Business to Promus Equity Partners for Up to $60 Million - Quiver Quantitative |
| 2026-02-12 | -3.0% | news | Seeking Alpha | Enovis: Valuation Is Too Low, But Needs To Differentiate On Growth |
| 2026-02-12 | -3.0% | news | Seeking Alpha | Enovis: Valuation Is Too Low, But Needs To Differentiate On Growth (NYSE:ENOV) - Seeking Alpha |
| 2023-05-04 | -3.0% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2023-10-20 | +2.9% | legal | SEC EDGAR | ENOV 8-K: 8.01 and (SEC Filing) |
| 2025-03-11 | +2.8% | news | Intellectia AI | ENOV Forecast — Price Prediction for 2026. Should I Buy ENOV? - Intellectia AI |
| 2023-12-05 | -2.7% | legal | SEC EDGAR | ENOV 8-K: 5.02 and (SEC Filing) |
| 2026-04-10 | +2.7% | news | GlobeNewswire | Enovis to Host First Quarter 2026 Results Conference Call on May 7th |
| 2026-04-10 | +2.7% | executive | Stock Titan | Enovis (NYSE: ENOV) HR chief reports 15,552 shares and stock options - Stock Titan |
| 2026-04-10 | +2.7% | news | Stock Titan | Enovis will release first-quarter results before a May 7 webcast - Stock Titan |
| 2025-08-27 | -2.4% | news | Seeking Alpha | Enovis: Healthy Recon Trends Vs. Market Apathy |
| 2026-02-10 | +2.3% | news | Finviz | Evercore ISI Bullish on Enovis (ENOV) Despite Weak Share Price Momentum - Finviz |
| 2026-01-06 | +2.2% | news | DirectorsTalk Interviews | Enovis Corporation (ENOV) Stock Analysis: A Strong Buy Amidst 69.94% Potential Upside - DirectorsTalk Interviews |
| 2024-02-22 | +2.1% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2026-04-09 | +2.1% | news | StockStory | 1 Value Stock to Research Further and 2 We Turn Down |
| 2024-08-07 | +2.1% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2025-08-08 | -2.0% | earnings | Seeking Alpha | Enovis raises 2025 revenue guidance to $2.275B amid CEO transition and product momentum |
| 2025-08-08 | -2.0% | earnings | Seeking Alpha | Enovis Corporation (ENOV) Q2 2025 Earnings Call Transcript |
| 2025-12-10 | +2.0% | legal | SEC EDGAR | ENOV 8-K: 1.01, 2.03 (SEC Filing) |
| 2023-10-25 | -1.9% | legal | SEC EDGAR | ENOV 8-K: 1.01, 2.03, 3.02 (SEC Filing) |
| 2023-05-22 | +1.7% | legal | SEC EDGAR | ENOV 8-K: 5.02, 5.07 (SEC Filing) |
| 2026-02-27 | +1.5% | earnings | Seeking Alpha | Enovis Corporation 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-27 | +1.5% | earnings | Seeking Alpha | Enovis targets $2.31–$2.37B 2026 revenue with 4–6% organic growth as margin expansion and innovation accelerate |
| 2026-02-27 | +1.5% | earnings | Seeking Alpha | Enovis Corporation (ENOV) Q4 2025 Earnings Call Transcript |
| 2022-04-07 | -1.4% | news | Zacks Investment Research | Enovis (ENOV) - Zacks Investment Research |
| 2022-04-07 | -1.4% | news | Zacks Investment Research | Should I buy Enovis (ENOV) - Zacks Investment Research |
| 2022-04-07 | -1.4% | earnings | Zacks Investment Research | What date does Enovis's (ENOV) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research |
| 2021-08-02 | +1.4% | legal | SEC EDGAR | ENOV 8-K: 8.01 and (SEC Filing) |
| 2025-07-30 | -1.4% | earnings | Yahoo Finance | The past five years for Enovis (NYSE:ENOV) investors has not been profitable - Yahoo Finance |
| 2022-08-04 | -1.4% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2026-04-01 | -1.3% | news | Simply Wall St. | Insider Activity Highlights These 3 Undervalued Small Caps Across Regions |
| 2024-05-11 | +1.2% | earnings | MarketBeat | Enovis (ENOV) Stock Forecast and Price Target 2026 - MarketBeat |
| 2024-01-03 | +1.2% | legal | SEC EDGAR | ENOV 8-K: 2.01, 7.01 (SEC Filing) |
| 2023-08-18 | +1.2% | analyst | TradingView | ENOV Forecast — Price Target — Prediction for 2027 - TradingView |
| 2022-11-18 | -1.1% | legal | SEC EDGAR | ENOV 8-K: 8.01 (SEC Filing) |
| 2025-12-15 | -1.1% | legal | SEC EDGAR | ENOV 8-K: 5.02 (SEC Filing) |
| 2021-04-29 | -1.0% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2026-04-23 | +1.0% | earnings | UBND thành phố Hải Phòng | ENOV (Enovis Corporation) shares rise 4.4 percent after 2025 fourth quarter EPS tops analyst estimates by 13 percent. - Trending Buy Opportunities - UBND thành phố Hải Phòng |
| 2026-04-06 | -1.0% | earnings | Cổng thông tin điện tử Tỉnh Sơn La | Can Enovis Corporation (ENOV) Stock Double in 2026 | ENOV Q4 Earnings: Beats Estimates by $0.11 - Real Trader Network - Cổng thông tin điện tử Tỉnh Sơn La |
| 2025-01-28 | -1.0% | legal | SEC EDGAR | ENOV 8-K: 8.01 and (SEC Filing) |
| 2026-03-10 | +1.0% | M&A | GuruFocus | Insider Buying: Oliver Engert Acquires Shares of Enovis Corp (EN - GuruFocus |
| 2025-08-09 | -1.0% | earnings | Yahoo Finance | Earnings Release: Here's Why Analysts Cut Their Enovis Corporation (NYSE:ENOV) Price Target To US$53.40 - Yahoo Finance |
| 2022-02-08 | +0.9% | legal | SEC EDGAR | ENOV 8-K: 5.02 (SEC Filing) |
| 2025-08-25 | -0.8% | news | TradingView | ENOV Stock Price and Chart — NYSE:ENOV - TradingView |
| 2026-03-16 | +0.8% | executive | Investing.com | Engert Oliver, chief administrative officer, buys Enovis Corp (ENOV) shares - Investing.com |
| 2025-05-06 | +0.7% | news | StockStory | Enovis (ENOV) Research Report - StockStory |
| 2026-03-03 | +0.5% | news | Stock Titan | Enovis (ENOV) CAO Oliver Engert buys 1,000 shares in market trade - Stock Titan |
| 2026-03-03 | +0.5% | news | Stock Titan | Enovis (ENOV) director Shirley Brady reports 1,492 shares withheld for taxes - Stock Titan |
| 2025-02-28 | -0.5% | news | Seeking Alpha | Enovis Continues To Languish Despite Decent Financial Results |
| 2025-12-08 | +0.5% | news | The Motley Fool | An Enovis (ENOV) Insider Bets Big on the Stock With a Purchase of 2,468 Shares - The Motley Fool |
| 2026-03-11 | -0.5% | earnings | simplywall.st | Enovis (ENOV) Is Down 5.5% After 2025 Loss And 2026 Revenue Outlook Update - Has The Bull Case Changed? - simplywall.st |
| 2021-11-04 | -0.4% | legal | SEC EDGAR | ENOV 8-K: 2.02 and (SEC Filing) |
| 2022-06-30 | +0.4% | legal | SEC EDGAR | ENOV 8-K: 5.02 and (SEC Filing) |
| 2022-03-14 | +0.3% | legal | SEC EDGAR | ENOV 8-K: 8.01 and (SEC Filing) |
| 2022-09-18 | +0.3% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Enovis (ENOV) - Zacks Investment Research |
| 2026-01-21 | +0.3% | news | Benzinga | Top 3 Health Care Stocks That Could Blast Off This Month - Benzinga |
| 2026-01-20 | -0.3% | news | Yahoo Finance | Enovis Corporation (ENOV): A Bull Case Theory - Yahoo Finance |
| 2024-05-22 | +0.3% | legal | SEC EDGAR | ENOV 8-K: 5.02, 5.03, 5.07 (SEC Filing) |
| 2026-03-24 | +0.3% | analyst | Yahoo Finance | Wall Street Analysts See a 100.71% Upside in Enovis (ENOV): Can the Stock Really Move This High? - Yahoo Finance |
| 2023-09-28 | +0.2% | legal | SEC EDGAR | ENOV 8-K: 1.01, 3.02 (SEC Filing) |
| 2021-12-30 | -0.2% | legal | SEC EDGAR | ENOV 8-K: 8.01 and (SEC Filing) |
| 2022-06-13 | +0.1% | legal | SEC EDGAR | ENOV 8-K: 5.02, 5.07 (SEC Filing) |
| 2024-07-15 | -0.1% | news | Seeking Alpha | Enovis Languishing Despite Respectable Performance (NYSE:ENOV) - Seeking Alpha |
| 2026-03-26 | -0.1% | news | Simply Wall St. | Undervalued Small Caps With Insider Action To Watch In March 2026 |
| 2022-01-12 | +0.1% | legal | SEC EDGAR | ENOV 8-K: 8.01 (SEC Filing) |
| 2024-02-15 | +0.0% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-04-19 | +0.0% | earnings | MarketBeat | Tributary Capital Management LLC Trims Stake in Enovis Corporation $ENOV - MarketBeat |
| 2026-04-19 | +0.0% | earnings | MarketBeat | Deroy & Devereaux Private Investment Counsel Inc. Acquires New Shares in Enovis Corporation $ENOV - MarketBeat |
| 2026-04-18 | +0.0% | news | Simply Wall St. | Does The Recent Rebound In Enovis (ENOV) Share Price Reflect Its True Worth? |
| 2024-07-18 | -0.0% | legal | SEC EDGAR | ENOV 8-K: 8.01 and (SEC Filing) |